# Sandra Demaria

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandra-demaria/

## Facts

| Field | Value |
| --- | --- |
| Citations | 39,684 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 81 |
| i10-index | 174 |
| Last Known Institution | Cornell University |
| OpenAlex ID | https://openalex.org/A5052554629 |
| ORCID iD | https://orcid.org/0000-0003-4426-0499 |
| Works | 450 |

## Researcher papers

- [The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014](https://scholariq.org/papers/the-evaluation-of-tumor-infiltrating-lymphocytes-tils-in-breast-cancer/)
- [Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for/)
- [Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research](https://scholariq.org/papers/assessing-tumor-infiltrating-lymphocytes-in-solid-tumors-a-practical-review-for-2/)
- [Cancer and Inflammation: Promise for Biologic Therapy](https://scholariq.org/papers/cancer-and-inflammation-promise-for-biologic-therapy/)
- [The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group](https://scholariq.org/papers/the-tale-of-tils-in-breast-cancer-a-report-from-the-international-immuno/)
- [Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer](https://scholariq.org/papers/topical-tlr7-agonist-imiquimod-can-induce-immune-mediated-rejection-of-skin/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cancer Cells and Metastasis](https://scholariq.org/topics/cancer-cells-and-metastasis/)

## Researcher university

- [Cornell University](https://scholariq.org/institutions/cornell-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.